Karuna Therapeutics falls on wider Q2 loss

Karuna Therapeutics

03/08/2023 18:52

** Shares of clinical-stage biopharmaceutical co Karuna
Therapeutics Inc  KRTX.O  down 6.4% at $185
    ** KRTX reports Q2 loss of $2.75 per share vs $2.17 per
share a year earlier
    ** Co promotes Jason Brown, senior vice-president, finance, 
to CFO
    ** Brown succeeds Troy Ignelzi, who will remain at the co
for a transition period through the end of Q3 2023
    ** Co says it has $1.4 bln in cash, which could fund
operations through 2026
    ** KRTX shares down 5.85% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))